BackRydex Health Care Inv Overview

Rydex Health Care Inv EBIT

Rydex Health Care Inv's EBIT is $150M, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$21.32M
↓ 46.64% YoY

As of Dec 31, 2023

Annual EBIT (TTM)

$147.62M

Trailing 12 months ending Dec 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Rydex Health Care Inv (RYHIX) FAQ

Rydex Health Care Inv (RYHIX) currently reports a EBIT of $150M as of December 2023. That is below the sector sector average of $2.6T. Use the charts on this page to explore Rydex Health Care Inv's EBIT history and peer comparisons.

Rydex Health Care Inv's EBIT of $150M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Rydex Health Care Inv reported $150M in EBIT as of December 2023. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Rydex Health Care Inv, and consider following RYHIX for alerts when major investors trade the stock.